These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21885847)

  • 21. CD98 regulates vascular smooth muscle cell proliferation in atherosclerosis.
    Baumer Y; McCurdy S; Alcala M; Mehta N; Lee BH; Ginsberg MH; Boisvert WA
    Atherosclerosis; 2017 Jan; 256():105-114. PubMed ID: 28012647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Wnt2 and WISP-1/CCN4 Induce Intimal Thickening via Promotion of Smooth Muscle Cell Migration.
    Williams H; Mill CA; Monk BA; Hulin-Curtis S; Johnson JL; George SJ
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1417-24. PubMed ID: 27199447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The VWF/LRP4/αVβ3-axis represents a novel pathway regulating proliferation of human vascular smooth muscle cells.
    Lagrange J; Worou ME; Michel JB; Raoul A; Didelot M; Muczynski V; Legendre P; Plénat F; Gauchotte G; Lourenco-Rodrigues MD; Christophe OD; Lenting PJ; Lacolley P; Denis CV; Regnault V
    Cardiovasc Res; 2022 Jan; 118(2):622-637. PubMed ID: 33576766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor Necrosis Factor Receptor-Associated Factor 5 Promotes Arterial Neointima Formation through Smooth Muscle Cell Proliferation.
    Willecke F; Rupprecht B; Gissler MC; Pfeiffer K; Anto-Michel N; Stachon P; Wolf D; Hilgendorf I; Hoppe N; Bode C; Zirlik A
    J Vasc Res; 2019; 56(6):308-319. PubMed ID: 31437850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcription factor CHF1/Hey2 regulates neointimal formation in vivo and vascular smooth muscle proliferation and migration in vitro.
    Sakata Y; Xiang F; Chen Z; Kiriyama Y; Kamei CN; Simon DI; Chin MT
    Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2069-74. PubMed ID: 15345511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of chlorinated and oxidized phospholipids in vascular tissue: implications for neointima formation.
    Greig FH; Hutchison L; Spickett CM; Kennedy S
    Clin Sci (Lond); 2015 May; 128(9):579-92. PubMed ID: 25524654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nrf2/Keap1 system regulates vascular smooth muscle cell apoptosis for vascular homeostasis: role in neointimal formation after vascular injury.
    Ashino T; Yamamoto M; Numazawa S
    Sci Rep; 2016 May; 6():26291. PubMed ID: 27198574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extensive Proliferation of a Subset of Differentiated, yet Plastic, Medial Vascular Smooth Muscle Cells Contributes to Neointimal Formation in Mouse Injury and Atherosclerosis Models.
    Chappell J; Harman JL; Narasimhan VM; Yu H; Foote K; Simons BD; Bennett MR; Jørgensen HF
    Circ Res; 2016 Dec; 119(12):1313-1323. PubMed ID: 27682618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CaMKII (Ca
    Nguyen EK; Koval OM; Noble P; Broadhurst K; Allamargot C; Wu M; Strack S; Thiel WH; Grumbach IM
    Arterioscler Thromb Vasc Biol; 2018 Jun; 38(6):1333-1345. PubMed ID: 29599132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular smooth muscle-MAPK14 is required for neointimal hyperplasia by suppressing VSMC differentiation and inducing proliferation and inflammation.
    Wu W; Zhang W; Choi M; Zhao J; Gao P; Xue M; Singer HA; Jourd'heuil D; Long X
    Redox Biol; 2019 Apr; 22():101137. PubMed ID: 30771750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intercellular transfer of miR-126-3p by endothelial microparticles reduces vascular smooth muscle cell proliferation and limits neointima formation by inhibiting LRP6.
    Jansen F; Stumpf T; Proebsting S; Franklin BS; Wenzel D; Pfeifer P; Flender A; Schmitz T; Yang X; Fleischmann BK; Nickenig G; Werner N
    J Mol Cell Cardiol; 2017 Mar; 104():43-52. PubMed ID: 28143713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased Jagged1 expression in vascular smooth muscle cells delays endothelial regeneration in arteriovenous graft.
    Guo Q; Huang F; Qing Y; Feng S; Xiao X; Wang Y; Liang M; Wang T; Mitch WE; Cheng J
    Cardiovasc Res; 2020 Nov; 116(13):2142-2155. PubMed ID: 31913453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. S-phase kinase-associated protein-2 (Skp2) promotes vascular smooth muscle cell proliferation and neointima formation in vivo.
    Wu YJ; Sala-Newby GB; Shu KT; Yeh HI; Nakayama KI; Nakayama K; Newby AC; Bond M
    J Vasc Surg; 2009 Nov; 50(5):1135-42. PubMed ID: 19878790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IQGAP1 links PDGF receptor-β signal to focal adhesions involved in vascular smooth muscle cell migration: role in neointimal formation after vascular injury.
    Kohno T; Urao N; Ashino T; Sudhahar V; Inomata H; Yamaoka-Tojo M; McKinney RD; Fukai T; Ushio-Fukai M
    Am J Physiol Cell Physiol; 2013 Sep; 305(6):C591-600. PubMed ID: 23657573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross talk between vascular smooth muscle cells and monocytes through interleukin-1β/interleukin-18 signaling promotes vein graft thickening.
    Li P; Li YL; Li ZY; Wu YN; Zhang CC; A X; Wang CX; Shi HT; Hui MZ; Xie B; Ahmed M; Du J
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):2001-11. PubMed ID: 25012128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Akt1 regulates vascular smooth muscle cell apoptosis through FoxO3a and Apaf1 and protects against arterial remodeling and atherosclerosis.
    Tucka J; Yu H; Gray K; Figg N; Maguire J; Lam B; Bennett M; Littlewood T
    Arterioscler Thromb Vasc Biol; 2014 Nov; 34(11):2421-8. PubMed ID: 25234814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Telomere damage promotes vascular smooth muscle cell senescence and immune cell recruitment after vessel injury.
    Uryga AK; Grootaert MOJ; Garrido AM; Oc S; Foote K; Chappell J; Finigan A; Rossiello F; d'Adda di Fagagna F; Aravani D; Jorgensen HF; Bennett MR
    Commun Biol; 2021 May; 4(1):611. PubMed ID: 34021256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MIA SH3 Domain ER Export Factor 3 Deficiency Prevents Neointimal Formation by Restoring BAT-Like PVAT and Decreasing VSMC Proliferation and Migration.
    Lei Y; Xu J; Li M; Meng T; Chen M; Yang Y; Li H; Zhuang T; Zuo J
    Front Endocrinol (Lausanne); 2021; 12():748216. PubMed ID: 34858331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leukotriene-C4 synthase, a critical enzyme in the activation of store-independent Orai1/Orai3 channels, is required for neointimal hyperplasia.
    Zhang W; Zhang X; González-Cobos JC; Stolwijk JA; Matrougui K; Trebak M
    J Biol Chem; 2015 Feb; 290(8):5015-5027. PubMed ID: 25540197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-195 regulates vascular smooth muscle cell phenotype and prevents neointimal formation.
    Wang YS; Wang HY; Liao YC; Tsai PC; Chen KC; Cheng HY; Lin RT; Juo SH
    Cardiovasc Res; 2012 Sep; 95(4):517-26. PubMed ID: 22802111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.